Beryl Drugs informs about SAST updates
Date: 19-08-2026Beryl Drugs has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi.
The above information is a part of company’s filings submitted to BSE.